Shopping Cart
- Remove All
- Your shopping cart is currently empty
EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.586 € | 6-8 weeks | |
50 mg | 2.071 € | 6-8 weeks | |
100 mg | 2.660 € | 6-8 weeks |
Description | EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist. |
Molecular Weight | 318.3 |
Formula | C16H13F3N4 |
Cas No. | 627525-33-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.